HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
Sys. Review
Stem cell–derived secretome may offer an alternative to live cell therapies for chronic wound healing
Review compares stem cell secretome to live cell therapies for leg ulcers
This narrative review synthesizes evidence on stem cell–derived secretome versus live cell therapies for diabetic, venous leg, and pressure …
A review looks at how stem cell secretome stacks up against live cell therapies for healing diabetic, venous, and pressure ulcers.
Frontiers
Jun 3, 2026
Orthopedics & Sports Medicine
Meta-analysis
Network meta-analysis ranks debridement strategies for venous and diabetic ulcers
Biological debridement ranks highest for healing chronic leg wounds in new analysis
Biological debridement ranked highest for wound healing and complete debridement in a network meta-analysis of 25 RCTs. Enzymatic and autoly…
Biological debridement shows the highest chance of healing wounds, but experts warn the evidence has gaps and needs careful reading.
Frontiers
May 22, 2026
Drug Pipeline
RCT
Octenidine gel plus hydrogel dressing improved healing progress versus silver-containing calcium alginate dressing in patients with chronic venous leg ulcers over 4 weeks
New gel therapy helps heal stubborn leg wounds faster than old silver dressings
This randomized controlled trial enrolled 60 patients with chronic venous leg ulcers.
A new gel treatment heals stubborn leg wounds faster than standard silver dressings in just four weeks.
Frontiers
Apr 28, 2026